郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

代谢疾病A new synthetic dual agonist of GPR120/GPR40 induces GLP-1 secretion and improves glucose homeostasis in mice.

期刊：Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie发表年份：2021作者：Gianluca Bianchini; Cecilia Nigro; Anna Sirico; Rubina Novelli; Immacolata Prevenzano; Claudia Miele; Francesco Beguinot; Andrea Aramini
阅读更多 →

代谢疾病Fc-GDF15 glyco-engineering and receptor binding affinity optimization for body weight regulation.

期刊：Scientific reports发表年份：2021作者：Ella Fung; Liya Kang; Diana Sapashnik; Susan Benard; Annette Sievers; Yan Liu; Guoying Yan; Jing Zhou; Linette Rodriguez; Weijun Ma; Wayne R Stochaj; Edward LaVallie; Liliana Wroblewska; Kerry Kelleher; Amy Tam; Olivier Bezy; Danna Breen; Jeffrey R C
阅读更多 →

代谢疾病Novel GLP-1/anti-apolipoprotein B bifunctional fusion protein alleviates diabetes and diabetic complications in combination with low-intensity ultrasound.

期刊：Life sciences发表年份：2021作者：Xing Li; Lianjie Bai; Yinghui Zhang; Ying Wang; Yang Shi; Huilin Liu
阅读更多 →

代谢疾病Homocysteine inhibits pro-insulin receptor cleavage and causes insulin resistance via protein cysteine-homocysteinylation.

期刊：Cell reports发表年份：2021作者：Xuan Zhang; Yuan-Yuan Qu; Lian Liu; Ya-Nan Qiao; Hao-Ran Geng; Yan Lin; Wei Xu; Jing Cao; Jian-Yuan Zhao
阅读更多 →